Hetrombopag

Small molecule

Phase 3underway

Evidence outlook · registrational

Chemotherapy-Induced Thrombocytopenia: registrational readout pending

No completed mid-stage readout is on record. Registrational readout expected around 2028-12.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (9)
Chemotherapy-Induced Thrombocytopenia
NCT07286032 · Jiangsu HengRui Medicine Co., Ltd.
2026-04-16 – 2029-06 · Patients With Chemotherapy-Induced Thrombocytopenia
What this study did
NCT05864014 · Jiangsu HengRui Medicine Co., Ltd.
2023-04-25 – 2025-09 · Chemotherapy-Induced Thrombocytopenia
What this study did
NCT03976882 · Jiangsu HengRui Medicine Co., Ltd.
2019-11-06 – 2023-02-22 · Chemotherapy-Induced Thrombocytopenia
What this study did
Other / comorbidity
NCT07925398 · Zhongda Hospital
2026-10-15 – 2028-08-30 · Thrombocytopenia, Hepatic Interventional Procedure
What this study did
NCT04737850 · Jiangsu HengRui Medicine Co., Ltd.
2021-03-29 – 2025-06-17 · Immune Thrombocytopenia
What this study did
NCT04961710 · Jiangsu HengRui Medicine Co., Ltd.
2019-09-19 – 2024-12-31 · Treatment-naive Severe Aplastic Anemia
What this study did
NCT03825744 · Jiangsu HengRui Medicine Co., Ltd.
2019-03-05 – 2024-07-03 · Severe Aplastic Anemia
What this study did
NCT03222843 · Jiangsu HengRui Medicine Co., Ltd.
2017-06-30 – 2021-01-07 · Idiopathic Thrombocytopenic Purpura
What this study did
Phase 2/3 (2)
Other / comorbidity
NCT05024877 · Peking Union Medical College Hospital
2021-10-01 – 2023-12-01 · MDS
What this study did
NCT05018936 · Peking Union Medical College Hospital
2021-10-01 – 2023-12-01 · Aplastic Anemia, Drug Effect
What this study did
Phase 2 (19)
Chemotherapy-Induced Thrombocytopenia
NCT07252375 · Fujian Cancer Hospital
2025-11-30 – 2028-11-30 · Nasopharyngeal Carcinoma (NPC), CTIT-Chemotherapy Induced Thrombocytopenia
What this study did
NCT07243418 · Fujian Cancer Hospital
2025-11-30 – 2028-05-30 · CTIT-Chemotherapy Induced Thrombocytopenia, Breast Cancer
What this study did
NCT07647029 · Fudan University
2026-07-16 – 2028-03-31 · Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
What this study did
NCT07408648 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
2026-04-15 – 2027-06-30 · Chemotherapy Induced Thrombocytopenia
What this study did
NCT05944211 · RenJi Hospital
2023-07 – 2027-01 · Chemotherapy-Induced Thrombocytopenia
What this study did
NCT07492693 · Changhai Hospital
2024-10-01 – 2026-08-01 · Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors
What this study did
NCT06099925 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
2023-10-16 – 2025-09-15 · Chemotherapy-induced Thrombocytopenia
What this study did
NCT05969158 · Sun Yat-sen University
2023-09-04 – 2025-08-01 · Chemotherapy-Induced Thrombocytopenia
What this study did
Other / comorbidity
NCT07010237 · Institute of Hematology & Blood Diseases Hospital, China
2025-02-01 – 2029-07-01 · Sever Aplastic Anaemia, Elderly (People Aged 65 or More), Immunosuppressive Treatment
What this study did
NCT07933146 · The First Affiliated Hospital of Zhengzhou University
2026-12-01 – 2028-10-31 · Thrombocytopenia
What this study did
NCT07334093 · Sun Yat-sen University
2026-01-31 – 2027-12-15 · Cancer Therapy-induced Thrombocytopenia (CTIT)
What this study did
NCT07101627 · Shanghai Pulmonary Hospital, Shanghai, China
2025-08-01 – 2027-06-30 · Lung Cancer
What this study did
NCT06478537 · Peking Union Medical College Hospital
2024-06-20 – 2027-06-20 · Immune Thrombocytopenia
What this study did
NCT05442632 · Fudan University
2022-07-25 – 2025-12-30 · Hepatopathy
What this study did
NCT06433830 · Sir Run Run Shaw Hospital
2022-05-10 – 2025-07-30 · Thrombocytopenia, Radiotherapy Side Effect
What this study did
NCT06036966 · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
2023-09-16 – 2025-07-15 · Thrombocytopenia
What this study did
NCT05394285 · Henan Cancer Hospital
2022-09-21 – 2025-07-01 · Breast Cancer
What this study did
NCT05392647 · Tongji Hospital
2022-07-01 – 2024-12-31 · Myelodysplastic Syndromes
What this study did
Phase 1/2 (1)
Other / comorbidity
NCT03557099 · Jiangsu HengRui Medicine Co., Ltd.
2018-06-20 – 2020-07-23 · Severe Aplastic Anemia
What this study did
Phase 1 (11)
Other / comorbidity
NCT05088655 · Jiangsu HengRui Medicine Co., Ltd.
2021-06-25 – 2023-11-02 · Sever Aplastic Anaemia
What this study did
NCT05088343 · Jiangsu HengRui Medicine Co., Ltd.
2020-09-07 – 2021-01-16 · Healthy Subjects
What this study did
NCT05088642 · Jiangsu HengRui Medicine Co., Ltd.
2020-09-28 – 2020-12-04 · Sever Aplastic Anaemia
What this study did
NCT04688008 · Jiangsu HengRui Medicine Co., Ltd.
2020-09-18 – 2020-10-30 · Bioavailability Study
What this study did
NCT05088174 · Jiangsu HengRui Medicine Co., Ltd.
2020-09-03 – 2020-10-22 · Sever Aplastic Anaemia
What this study did
NCT03977805 · Jiangsu HengRui Medicine Co., Ltd.
2019-05-25 – 2019-06-13 · Healthy
What this study did
NCT03603132 · Jiangsu HengRui Medicine Co., Ltd.
2018-07-14 – 2018-08-17 · Immune Thrombocytopenia
What this study did
NCT02614846 · Jiangsu HengRui Medicine Co., Ltd.
2015-08 – 2016-03 · Chronic Idiopathic Thrombocytopenic Purpura
What this study did
NCT02403440 · Jiangsu HengRui Medicine Co., Ltd.
2014-04 – 2015-04 · Purpura, Thrombocytopenic, Idiopathic
What this study did
NCT02409394 · Jiangsu HengRui Medicine Co., Ltd.
2014-03 – 2014-04 · Healthy
What this study did
NCT01830660 · Jiangsu HengRui Medicine Co., Ltd.
2012-04 – 2013-06 · Healthy
What this study did
Phase 4 (4)
Other / comorbidity
NCT07788456 · Institute of Hematology & Blood Diseases Hospital, China
2026-06-22 – 2027-06-30 · ITP - Immune Thrombocytopenia
What this study did
NCT06562738 · The Third People's Hospital of Chengdu
2024-06-01 – 2025-03-31 · Thrombocytopenia
What this study did
NCT05311930 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
2022-05-01 – 2024-12-30 · Primary Immune Thrombocytopenia
What this study did
NCT05575986 · Huazhong University of Science and Technology
2022-10 – 2023-12 · Malignant Tumors of the Digestive System, Trombocitopenia
What this study did
Early phase / not applicable (2)
Other / comorbidity
NCT06818916 · Beijing Children's Hospital
2024-06-30 – 2027-07-31 · Delayed Platelet Engraftment, Neuroblastoma, Autologous Hematopoietic Stem Cell Transplantation
What this study did
NCT05727917 · Institute of Hematology & Blood Diseases Hospital, China
2023-01-01 – 2024-10-31 · Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

(13 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow Hetrombopag to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (9)
April 2027 (3)
Phase 2Chemotherapy-Induced ThrombocytopeniaNot yet recruiting
Est. primary completion 2027-04-15 · NCT07408648 · CT.gov ↗
What to watch
Phase 2Lung CancerNot yet recruiting
Est. primary completion 2027-04-30 · NCT07101627 · CT.gov ↗
What to watch
Early phase / not applicableDelayed Platelet Engraftment, Neuroblastoma, Autologous Hematopoietic Stem Cell TransplantationRecruiting
Est. primary completion 2027-04-30 · NCT06818916 · CT.gov ↗
What to watch
May 2027 (1)
Phase 4ITP - Immune ThrombocytopeniaRecruiting
Est. primary completion 2027-05-30 · NCT07788456 · CT.gov ↗
What to watch
June 2027 (1)
Phase 2Immune ThrombocytopeniaRecruiting
Est. primary completion 2027-06-20 · NCT06478537 · CT.gov ↗
What to watch
September 2027 (1)
Phase 3Thrombocytopenia, Hepatic Interventional ProcedureNot yet recruiting
Est. primary completion 2027-09-15 · NCT07925398 · CT.gov ↗
What to watch
November 2027 (2)
Phase 2Cancer Therapy-induced Thrombocytopenia (CTIT)Not yet recruiting
Est. primary completion 2027-11-15 · NCT07334093 · CT.gov ↗
What to watch
Phase 2Chemotherapy-Induced ThrombocytopeniaNot yet recruiting
Est. primary completion 2027-11-30 · NCT07243418 · CT.gov ↗
What to watch
December 2027 (1)
Phase 2ThrombocytopeniaNot yet recruiting
Est. primary completion 2027-12-30 · NCT07933146 · CT.gov ↗
What to watch
2028 (4)
February 2028 (1)
Phase 2Chemotherapy-Induced ThrombocytopeniaRecruiting
Est. primary completion 2028-02-29 · NCT07647029 · CT.gov ↗
What to watch
May 2028 (1)
Phase 2Chemotherapy-Induced ThrombocytopeniaNot yet recruiting
Est. primary completion 2028-05-30 · NCT07252375 · CT.gov ↗
What to watch
December 2028 (2)
Phase 3Chemotherapy-Induced ThrombocytopeniaRecruiting
Est. primary completion 2028-12 · NCT07286032 · CT.gov ↗
What to watch
Phase 2Sever Aplastic Anaemia, Elderly (People Aged 65 or More), Immunosuppressive TreatmentRecruiting
Est. primary completion 2028-12-31 · NCT07010237 · CT.gov ↗
What to watch

See the full readout calendar ↗